Rxivist logo

Serum triglycerides in Alzheimer’s disease: Relation to neuroimaging and CSF biomarkers

By Megan M. Bernath, Sudeepa Bhattacharyya, Kwangsik Nho, Dinesh Kumar Barupal, Oliver Fiehn, Rebecca Baillie, SL Risacher, Matthias Arnold, Tanner Jacobson, John Q. Trojanowski, Leslie M. Shaw, Michael W. Weiner, P. Murali Doraiswamy, Rima Kaddurah-Daouk, Andrew J Saykin, for the Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Metabolomics Consortium

Posted 13 Oct 2018
bioRxiv DOI: 10.1101/441394

Objective To investigate the association of triglyceride (TG) principal component scores with Alzheimer’s disease (AD) and the “A/T/N/V” (Amyloid, Tau, Neurodegeneration, and Cerebrovascular disease) biomarkers for AD. Methods Serum levels of 84 TG species were measured using untargeted lipid profiling of 689 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort including 190 cognitively normal older adults (CN) and 339 mild cognitive impairment (MCI) and 160 AD. Principal component analysis with factor rotation was used for dimension reduction of TG species. Differences in principal components between diagnostic groups and associations between principal components and AD biomarkers (including CSF, MRI and [18F]FDG-PET) were assessed using a multivariate generalized linear model (GLM) approach. In both cases, the Bonferroni method of adjustment was employed to correct for multiple comparisons. Results The 84 TGs yielded 9 principal components, two of which consisting of long-chain, polyunsaturated fatty acid-containing TGs (PUTGs), were significantly associated with MCI and AD. Lower levels of PUTGs were observed in MCI and AD compared to CN. PUTG principal component scores were also significantly associated with hippocampal volume and entorhinal cortical thickness. In participants carrying APOE ε4 allele, these principal components were significantly associated with CSF amyloid-β1-42 values and entorhinal cortical thickness. Conclusions This study shows PUTG component scores significantly associated with diagnostic group and AD biomarkers, a finding that was more pronounced in APOE ε4 carriers. Replication in independent larger studies and longitudinal follow-up are warranted.

Download data

  • Downloaded 862 times
  • Download rankings, all-time:
    • Site-wide: 16,237 out of 100,591
    • In neuroscience: 2,625 out of 17,924
  • Year to date:
    • Site-wide: 5,943 out of 100,591
  • Since beginning of last month:
    • Site-wide: 10,677 out of 100,591

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide

PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)

News

  • 20 Oct 2020: Support for sorting preprints using Twitter activity has been removed, at least temporarily, until a new source of social media activity data becomes available.
  • 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
  • 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
  • 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
  • 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
  • 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
  • 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
  • 22 Jan 2019: Nature just published an article about Rxivist and our data.
  • 13 Jan 2019: The Rxivist preprint is live!